SSID Group said that the assets acquired in the deal will complement its gastric health portfolio and let it offer a broader range of tests to US labs.

Roche confirmed its full-year outlook with sales expected to increase in the mid-single-digit percent range at constant exchange rates. The firm added that EPS for full-year 2025 is expected to ...

The company said during a conference call following release of its Q1 2025 results that it purchases roughly 80 percent of ...

The Canadian firm’s SpineStat assay is used to detect autoantibodies to the protein biomarker 14-3-3eta to aid the diagnosis of axial spondyloarthritis.

The company, also known as DRW, shared early data on its forthcoming multiplex qPCR-based platform and infectious disease ...

NEW YORK – Roche announced on Wednesday that it has received CE marking for its Chest Pain Triage algorithm to help rule in and rule out heart attacks in the emergency department.

NEW YORK – Diagnostics firm Genalyte is laying the groundwork for the commercial launch of its Merlin point-of-care clinical analyzer. The San Diego-based firm has completed its submission to the US ...

The firm also reported its Life Sciences segment revenues fell 4 percent in the quarter, while Diagnostics revenues decreased 3 percent.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

NEW YORK – Laboratory Corporation of America said Monday that it has acquired the ambulatory outreach lab business of healthcare system North Mississippi Health Services (NMHS) and become a referral ...